Completed
Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
NCT00495391
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
- Locations
-
- VA Palo Alto Healthcare System Palo Alto, California, United States
- Stanford University School of Medicine Stanford, California, United States
- Yale University Digestive Diseases New Haven, Connecticut, United States
- University of Florida Hepatology Gainesville, Florida, United States